Molecular-based environmental risk assessment of three varieties of genetically engineered cows

The development of animal biotechnology has led to an increase in attention to biosafety issues. Here we evaluated the impact of genetically engineered cows on the environment. The probability of horizontal gene transfer and the impact on the microbial communities in cow gut and soil were tested using three varieties of genetically engineered cows that were previously transformed with a human gene encoding lysozyme, lactoferrin, or human alpha lactalbumin. The results showed that the transgenes were not detectable by polymerase chain reaction (PCR) or quantitative real-time PCR in gut microbial DNA extracts of manure or microbial DNA extracts of topsoil. In addition, the transgenes had no impact on the microbial communities in cow gut or soil as assessed by PCR-denaturing gradient gel electrophoresis or 16S rDNA sequencing. Furthermore, phylogenetic analyses showed that the manure bacteria sampled during each of the four seasons belonged primarily to two groups, Firmicutes and Bacteroidetes, and the soil bacteria belonged to four groups, Firmicutes, Bacteroidetes, Actinobacteria, and α-proteobacteria. Other groups, such as β-proteobacteria, γ-proteobacteria, δ-proteobacteria, ε-proteobacteria, Spirochaetes, Acidobacteria, Chloroflexi, and Nitrospira, were not dominant in the manure or soil.     

转基因微生物生态学及大田释放风险评价研究

向环境中释放转基因微生物可能会带来一系列的安全问题．在大面积释放之前必须对转基因微生物在环境中发生基因转移的潜力、存活能力、扩散能力及对生态系统的潜在影响等进行生态学研究和风险评价,同时还要探索有效的检测方法和风险评价策略．该研究有助于分子生态学的发展和生物技术的安全应用,具有重要的理论和实践意义．     

Detection of genetically engineered traits among bacteria in the environment.

The release of genetically engineered microorganisms (GEMs) into the environment has, as its main aims, the benefits of improved agricultural yield and control of environmental pollution. However, effective and safe release programmes necessitate the development of sensitive, selective detection methods to monitor the environmental impact of released organisms.     

Recommendations for the design of laboratory studies on non-target arthropods for risk assessment of genetically engineered plants

This paper provides recommendations on experimental design for early-tier laboratory studies used in risk assessments to evaluate potential adverse impacts of arthropod-resistant genetically engineered (GE) plants on non-target arthropods (NTAs). While we rely heavily on the currently used proteins from Bacillus thuringiensis (Bt) in this discussion, the concepts apply to other arthropod-active proteins. A risk may exist if the newly acquired trait of the GE plant has adverse effects on NTAs when they are exposed to the arthropod-active protein. Typically, the risk assessment follows a tiered approach that starts with laboratory studies under worst-case exposure conditions; such studies have a high ability to detect adverse effects on non-target species. Clear guidance on how such data are produced in laboratory studies assists the product developers and risk assessors. The studies should be reproducible and test clearly defined risk hypotheses. These properties contribute to the robustness of, and confidence in, environmental risk assessments for GE plants. Data from NTA studies, collected during the analysis phase of an environmental risk assessment, are critical to the outcome of the assessment and ultimately the decision taken by regulatory authorities on the release of a GE plant. Confidence in the results of early-tier laboratory studies is a precondition for the acceptance of data across regulatory jurisdictions and should encourage agencies to share useful information and thus avoid redundant testing.     

Treating cancer with genetically engineered T cells

Administration of ex vivo cultured, naturally occurring tumor-infiltrating lymphocytes (TILs) has been shown to mediate durable regression of melanoma tumors. However, the generation of TILs is not possible in all patients and there has been limited success in generating TIL in other cancers. Advances in genetic engineering have overcome these limitations by introducing tumor-antigen-targeting receptors into human T lymphocytes. Physicians can now genetically engineer lymphocytes to express highly active T-cell receptors (TCRs) or chimeric antigen receptors (CARs) targeting a variety of tumor antigens expressed in cancer patients. In this review, we discuss the development of TCR and CAR gene transfer technology and the expansion of these therapies into different cancers with the recent demonstration of the clinical efficacy of these treatments.     

Transportability of confined field trial data for environmental risk assessment of genetically engineered plants: a conceptual framework

It is commonly held that confined field trials (CFTs) used to evaluate the potential adverse environmental impacts of a genetically engineered (GE) plant should be conducted in each country where cultivation is intended, even when relevant and potentially sufficient data are already available from studies conducted elsewhere. The acceptance of data generated in CFTs “out of country” can only be realized in practice if the agro-climatic zone where a CFT is conducted is demonstrably representative of the agro-climatic zones in those geographies to which the data will be transported. In an attempt to elaborate this idea, a multi-disciplinary Working Group of scientists collaborated to develop a conceptual framework and associated process that can be used by the regulated and regulatory communities to support transportability of CFT data for environmental risk assessment (ERA). As proposed here, application of the conceptual framework provides a scientifically defensible process for evaluating if existing CFT data from remote sites are relevant and/or sufficient for local ERAs. Additionally, it promotes a strategic approach to identifying CFT site locations so that field data will be transportable from one regulatory jurisdiction to another. Application of the framework and process should be particularly beneficial to public sector product developers and small enterprises that develop innovative GE events but cannot afford to replicate redundant CFTs, and to regulatory authorities seeking to improve the deployment of limited institutional resources.     

Advancing environmental risk assessment for transgenic biofeedstock crops

Transgenic modification of plants is a key enabling technology for developing sustainable biofeedstocks for biofuels production. Regulatory decisions and the wider acceptance and development of transgenic biofeedstock crops are considered from the context of science-based risk assessment. The risk assessment paradigm for transgenic biofeedstock crops is fundamentally no different from that of current generation transgenic crops, except that the focus of the assessment must consider the unique attributes of a given biofeedstock crop and its environmental release. For currently envisioned biofeedstock crops, particular emphasis in risk assessment will be given to characterization of altered metabolic profiles and their implications relative to non-target environmental effects and food safety; weediness and invasiveness when plants are modified for abiotic stress tolerance or are domesticated; and aggregate risk when plants are platforms for multi-product production. Robust risk assessments for transgenic biofeedstock crops are case-specific, initiated through problem formulation, and use tiered approaches for risk characterization.     

Single-molecule tracking of myosins with genetically engineered amplifier domains

We combined protein engineering and single molecule measurements to directly record the step size of a series of myosin constructs with shortened and elongated artificial neck domains. Our results show that the step size has a clear linear dependence on the length of the neck domain and we also established that mechanical amplification in the myosin motor is based on a rotation of the neck domain relative to the actin-bound head. For all our constructs, including those with artificial necks, the magnitude of the neck rotation concurrent with the displacement step was approximately 30 degrees. The engineered change in the step size of myosin marks a significant advance in our ability to selectively modify the functional properties of molecular motors.     

Applicability of indicator monitoring to ecological risk assessment

Although ecological risk assessment (ERA) and environmental monitoring would seem to be potentially complimentary activities, they have been disjunct in practice. This is because of differences in goals and products. Environmental monitoring determines status and trends in indicators to determine whether the environment is improving. ERA estimates effects of stressors on endpoint attributes to support decision making. Indicators are, by definition, indicative of some unmeasured condition. Assessment endpoints are valued properties of the environment that are susceptible to stressors of concern. Indicators are justified by the logic of the monitoring program, which may be self-referential. Assessment endpoints are justified by their potential susceptibility and by environmental policies and public values. Indicators are often expressed in terms of indices or scores that obscure the actual condition of the environment. Because assessment endpoints must be clear to decision makers and the public, they require real units of actual environmental properties. Monitoring programs are peripherally concerned about causal relationships, while risk assessment is devoted to elucidating causal relationships. As a result, risk assessments may use the results of monitoring studies, but only after disaggregating the indicators to their components and choosing those that are appropriate. Monitoring programs could be more useful if they used a risk-based approach to address important problems rather than simply tracking indicators.     

Overview: The future of ecological risk assessment

Risk assessment has become a popular tool to help solve ecological problems. The basic concept is not new and has been applied to diverse decision problems. The application to ecological problems, especially complex ecological problems, is fairly recent and controversial. The fundamental and most important elements of the controversy revolve around two key points: (1) a person's implicit “world view;”; and (2) the assumption of who (or what) receives the benefits and who (or what) pays the costs for ecological “decisions.”; A person's attitude toward risk assessment is, at least implicitly, defined by a world view. It is this world view that defines how each of us reacts to risk assessment applied to ecological problems. How the question of benefits and costs is defined also defines the appropriate use, if any, of ecological risk assessment. The future of ecological risk assessment will almost certainly follow the course of other analytical tools: enthusiastic support, rapid, widespread adoption and use; then disillusionment and rapid replacement with newer approaches, but with continued use for a greatly constrained set of ecological issues.